Acorda reports deaths in Parkinson's trial, shares plunge

(Reuters) - Acorda Therapeutics Inc said it halted enrolling patients in two late-stage safety studies of its Parkinson's disease drug following deaths, sending its shares tumbling more than 40 percent in premarket trading.